Daiichi Sankyo Europe GmbH

Daiichi Sankyo Europe GmbH is a subsidiary of the global pharmaceutical company Daiichi Sankyo Co., Ltd. The company focuses on the development and commercialization of innovative pharmaceutical products to address unmet medical needs. With a strong emphasis on research and development, it aims to provide new treatment options for patients in various therapeutic areas, including oncology, cardiovascular diseases, and metabolic disorders. The company collaborates with healthcare professionals, academic institutions, and other stakeholders to advance medical science and improve patient outcomes. It operates in multiple countries across Europe, leveraging its extensive network to ensure the availability of its products. The company is committed to sustainability and corporate social responsibility, implementing various initiatives to reduce its environmental impact and contribute to the well-being of communities. Its workforce is composed of highly skilled professionals dedicated to making a difference in the lives of patients. The company continuously invests in cutting-edge technologies and infrastructure to support its mission of delivering high-quality medicines. Through its efforts, it strives to be a trusted partner in the healthcare industry, known for its innovation, integrity, and commitment to excellence.